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The human keratinocyte cell line HaCaT has a basal 
phett'otype and secretes an insulin-like growth factor 
(IGF) binding protein, IGFBP-3, which modulates its 
IGF-1 response. Keratinocytes are highly responsive 
to mitogenic stimulation by IGF-1 and epidermal 
growth factor (EGF), but the effect of these growth 
factors on IGFBP secretion by keratinocytes is not 
known. We investigated the effects ofiGF-1 and EGF, 
as well as three other skin-growth regulators, retinoic 
acid, basic fibroblast growth factor, and dexametha-
sone, on mitogenic stimulation and IGFBP-3 produc-
tion in HaCaT cells. IGF-1 and EGF were strongly 
mitogenic, whereas retinoic acid, basic fibroblast 
growth factor, and dexamethasone were not signifi-
cantly mitogenic. IGF-1 increased the level of 
IGFBP-3 in cell-conditioned medium by up to two-
I nsulin-like growth factor I (IGF-l), which is produced in the dermis, is a potent mitogen for keratinocytes [1-3]. T he essential role of IGF-1 in normal epidermal growth was recently ill ustrated in transgenic mice that lacked the IGF-1 receptor: the mice showed a severe inhibi tion of cell 
progression fi·om the basal to the spinous layer of the epidermis, 
resu lting in thin , translucent skin [4]. Because it is the basal ce lls of 
the epiderm is that have the highest concentratio n of lGF-I recep-
tors [5], it is like ly tha t the basal layer is an important cellular target 
for lGF-1. We have previously demonstrated that the ce ll line 
HaCaT, wh ich has the characteristics of a pmcly basal epiderma l 
kcratinocytc [6], synthesizes predominantly TGF binding protein-3 
(IGFBP-3) in cu lture [7]. /11 situ hybridization studies from our 
laboratory show that IGFBP-3 syn thesis in skin is indeed concen-
trated in the basal layer [8_1. The HaCaT cel l line thus provides a 
va lu able model for studying IG FBl>-3 regulation in the basal 
epidermis. Because IGFBPs [9] and lGFBP-3 in particular [7, 10, 11] 
have been shown to signifi cantly influence the response to !GF-1 in 
a variety of systems, IGFBP production by basa l keratinocytes 
certainly has the potential to affect their response to IGF-l i11 vivo. 
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fold, whereas EGF caused a twentyfold reduction in 
IGFBP-3. Retinoic acid and basic fibroblast growth 
factor had only minor effects on IGFBP-3 and dexa-
methasone had no effect. IGF-1 stimulation of 
IGFBP-3 did not involve increases in IGFBP-3 
mRNA; however, EGF, consistent with its effect on 
IGFBP-3 protein, caused a fivefold reduction in 
IGFBP-3 mRNA. In summary, EGF profoundly in-
hibited IGFBP-3 synthesis in basal keratinocytes, 
whereas IGF-1 increased IGFBP-3 levels by a post-
transcriptional mechanism. We hypothesize that by 
inhibiting IGFBP-3 production in basal keratino-
cytes, epidermal mitogens such as EGF might stimu-
late epidermal growth indirectly by increasing local 
IGF-1 availability. Key IIIOJ'ds: ski11lepidermis. J llwest 
Dumatol 105:602-607, 1995 
It follows that other skin-growth regulators could alter the lGF-I 
responsiveness of basal kcr·atinocytcs by regulating IGFBP-3. 
W c therefore investigated the efFect of several horm ones known 
to influence skin growth, inclnding lGF-1, on IGFBP production by 
basal kcratinocytes. Like IGF-1, epidermal gr·owth factor (EGF) is a 
potent mitogen for kcratinocytes [12] and its target in the epider-
mis, the EGF receptor, is also largely limited to the basal keratino-
cytes [13,14] . Basic fibroblast growth f.1ctor (bFGF) is another 
mitogen of cultu red keratinocytcs [1, 15) and is widely used to 
stim ulate keratinocytc g rowth in serum-free cu lture [1 6] . but its 
efFects on lGFBP-3 production arc not known. Retinoic ac id and 
corticosteroids arc widely used in the treatment of psoriasis and 
other skin disorders. Retinoic acid is mitogenic in cultured skin 
keratinocytes [1 7] and inhibi ts the dill'e rentiation of kcratinocytes 
[18) including HaCaT cells [19]. Although both retinoic acid [20] 
and dexamethasone [21] alter IGFBP expression in other ce ll types, 
thei r effects on IGFBP production in the epidermis have not been 
investigated. 
T he findings presented here indicate that fGF-1 and EGF do alter 
IGFBP-3 production by HaCaT basal keracinocytcs, while the other 
hormones tested had littl e effect. We exam in e these obse rvations in 
detail and discuss their relevance in no rmal and disordered epider-
mal g rowth. 
MATEil..IALS AND METHODS 
Materials Recombinant human 1GF-1 was a gift from Dr. A. Skottner 
(Kab iPharmacia , Peptide Hormones. Sweden). Jl..ecombinant Jurman EGF 
]3- 125 1-iodotyrosyl]J GF-1 (2000 Ci/mmol) and fm cthyl-' 1-lJthymidine (6.70 
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C i/ mmol) were fro m Amers ham. Sydn ey, Australia. l3ovine bFGF and 
rando m primed DNA labe ling kit were fro m l3oelu·inger Mannhcim (North 
Ryde, NSW. Australia) . Dexamethasone was from Sigma C hcrni cal Co, St. 
Lou is. MO, and trans-retinoi c acid was provided by Dr. U. Novak (Royal 
Melbourne H osp ital , Melbourne , Austra li a). T he eDNA for human 
IGFBP-3 [22J was kindl y provided b)' Dr. S. Shimasaki (Whi ttier Institute, 
La Joll a, CA) and the syn thetic o ligonucleotide complem enta ry to ISS 
ribosoma l l'lNA was fi·om Dr. A . Herington, Roya l C hildren 's H osp ital , 
Melbourne, Australia . 
Cells The differen tiated human keratinocytc cell line , HaC aT [G] . was 
kind ly provided by Prof. N. Fusenig, German Cancer R.esea rch Centre, 
Heidelberg, German y. Ce ll s at passage numbers 33 to 36 were maintaiued 
as monolayer cultures in S'V., C02 at 37°C in keratinocyte se rum-fi·ec 
medium (G ibco), containing EGF and bovine pimitary extract as suppli ed. 
Media containing fCta l bovine scrunt ' verc avoided beca use of the hig h 
content of IG I=-1 binding prote ins in se rum. 
Assay of Mitogenic Activi ty T he mitogenic effect of each hormo ne o n 
HaCaT cells was assayed using thymidine inco rpo ratio n and direct ce ll 
cou.nting. 
For chyn1idinc incorporatio n assays, ce ll s were g rown to 3 d post 
conflu ence in 2-cm 2 weLls with dail y m edium changes of keratinocyte 
sc rutn-frec n1c.diun1 , and the m e dillln was c hanged to Dulbccco ·s n1 odifi ed 
Eagle's m edium (DMEM) (Cytos ystems, Australia). with the fo llowing 
additio ns: 25 mM HEPES. 0.19')1,, (w/v) sodium bicarbo na te, 0.03% (w / v) 
glutamine (S igma). 50 IU/m l peni cillin , and 50 /-Lg/m l strepto m ycin (Flo w 
Laboratori es). After 24 h , hormo nes we re added to trip li cate we ll s at the 
concentrations indicated in 0 .5 ml fresh DMEM conta ining 0.02'!/, bov ine 
serum albumin (Sigma mo lecular biology grade) and incubated fo r a furt her 
21 b befo re m easuring thymidine incorporation rates. ['HJ-th ymidine (0. ·1 
JLCi/ well ) was added and the cell s incubated fo r a further 3 h. The m edium 
was the n asp irated and the cell s washed o nce with icc-co ld phosphate-
buffered sa line and twice with icc-cold 10% trichl o roacetic ac id. T he 
trichloroacetic acid- precipi tated m o no layers were then so lubilized with 
0.25 M NaO H (200 f..d /well) and tra nsfe rred to sc intillatio n v ial s, and 
radioactivity w as dete rmin ed by liq uid scin tillat ion counting (Pharmacia 
Wallac 14 I 0 liquid scin till ation coun te r). Percent thymidine incorpo ration 
compared to untreated cell s was exp ressed as the m ean oftripli c;Hes ± SD. 
To m easure effects o n ce ll nun1bc r. we used the cell-countin g assay of 
Schulz el nl f23 J develo ped specifica lly fo r the HaCaT cell line. Briefly. 
HaCaT cell s were p la ted at 5000 cell s per well (approximately 1 0':>~. 
confl uent) in a 96-well tissue-cu lture plate (Falco n number 3072, Becton 
Dickinson Labware) in kera t inocyte serum-free m edium . Afte r 24 h. 
medium was changed to DMEM . and afi:cr a fur ther 24 h ho rm o nes we re 
added in quadrupli cate well s in 200 f..d DMEM. After 4 d . ce ll s we re fixed 
and counted exac tly as described [23 J. 
Western Ligand Blotting For analysis of IGFBPs by Westem li gand 
blot, cells Vlcrc gro\vn to 3 d post confluence in 2 - cm 2 wells with daily 
n1cdi un1 changes of kc ratinocytc sc rwn-fi·cc m edium , and the n1 cd ium was 
changed to DMEM as above. Afte r 24 h , ho rm ones were added in fres h 
DMEM dail y for 4 d. After the fi nal addition , the cell s were incubated for 
2 d, and the ce ll-conditioned medium was co ll ected. The ce ll s were 
trypsirtized and counted in a Coulte r Industrial I) Counter, Coulter 
Bedfordshire. UK. 
HaCaT conditi oned m edium (250 I-Ll) was concentrated by adding 750 f..l l 
cold ethanol, incubating at - 20°C fo r 2 h and centrifu ging at 16 ,000 X g for 
20 min at 4°C . T he resulting pelle t was air dried. res uspended th o ro ughl y in 
non-reducing Laemmli sample bu fFer , heated to 90°C for 5 min , and 
separated o n 12'Y, sodium dodccylsul f.1tc-po lyacrylamide gel electrophores is 
acco rdin g to the method of Laemmli J24'J. Sl!para ted proteins were elcctro-
phoretica ll y transfe rred to ni trocellulose membrane (0.45 /-Llll, Schle icher 
and Schuell , Dassel. Germany) in a buffe r cou c;r ining 25 ruM tri s, 192 mM 
glycine , and 20% (v/v) m ethano l. IGFB Ps were then visua li zed by the 
procedure of 1-l osscnlopp ct nl J'25.J, using [ 125 1]-IG F-1, fo llowed by auto-
rad iograph)' · Autoradiographs w ere scanned in a J3io l'l;rd Model GS-670 
Imaging Densito meter and band densities w ere determined using the 
Mol ecular Ana lys t program. 
A utorad iographs were exposed so that b;md o p tica l densities were 
directly pro porLi o nal to relative amounts of IG FBP-3 (empiri ca ll y deter-
mined, data not shown). Relati ve band intensities were then staudardi zed 
against the munbCJ: of cell s in the assayed well . Cell numbers varied by less 
than 20%. The data shown represent relative IGFl3P-3 levels compared to 
control untreated ce lls and arc the m ea n ~-cl ;~tivc level f:i-on1 three separa te 
experim ents ± SD. 
N orthern Analysis Fo r anal ysis o f IG Fl3P ml'lNAs, HaCaT cells were 
grown to 3 d post-confluence in 60-cm 2 di shes with dail y medium changes 
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of keratinocyte serum-free m edium. and the m edium was changed to 
DMEM as above. Afte r 24 h , hormones we re added in fi·es h D MEM dail y 
fo r 2 d. Twenty-fo ur hours after the second <Jdditio n , total l'lNA was 
prepared by the method of C ho m czynski and Sacchj [26] and analyzed by 
Northe rn blotting as described below. 
Total l'lNA (20 /-Lg) was denatured at 55 °C for I h in J M g lyoxal, 50% 
dimethylsulfox ide, 10 rnM NaP0 4 , pH 7.0, and e lectropho resed in a 1% 
agarosc gel in 10 mM N aP0 .1• pH 7 .0. Afi:cr transfer to Hybond-N 
(Am crsham) in 20 X SSC (3 M NaC I, 0.3 M trisodium citrate dihydrate, pl-1 
7.0) . l'lNA was ul travio let cross-linked (2.5 j /cm 0) and the membrane 
pre-hybridized fo r 5 h at 48°C and probed overnight at 48°C in a solution 
containing 2 .5 X SSC (0 .38 M NaC I, 0 .038 M trisodium citrate dihydra te , 
pH 7.0), 50% (v / v) fonnamide , 0.05% (w/v) sodium pyrophosphate, 5 X 
Denhardt's solu tion, 25 mM sodium phos phate, 0.5% (w/v) sodium 
dodecy lsulfirte and J 00 /-Lg/ml of boil ed herring sperm DNA. T he mem-
bra ne was probed with cD NAs for human IGFBP-3 o r -4 labeled with 
a -f32P]-dCTP (Amcrsham , 3000 C i/ mmol) by random o ligonucleotide 
printin g. T he m embrane was then was hed fo r 3 X ·1 0 min in 2 X SSC/0.1 % 
sodium dodccylsulfiltc at 48°C and auto radiograph ed overnight. To correct 
for possible diffe rences in J'lNA loading. tir e membrane was re-probed with 
a syn thetic o ligonucleotide complem entary to I SS ribosomal R..N A after 
stripping o f hybridized , labeled cDNAs in several changes ofS mM tr·is 1-I C I. 
pl-1 8.0. 2 mM eth ylcnediarninetetraaceti c acid, 0. 1 X Denhardt 's. at 65°C 
fo r 2 h. The membrane was pre-hybridized for 5 h at 65 °C in the same 
pre-hybridizing so lutio n as before except that fo nnamide was o mi tted . T he 
·1ss o li go nucleo tide was end- labeled with y-[32 P]-ATP (3000 Ci / mmol) 
with T4 po lynucleotide ki nase (Boehringer Mannheim) and added to the 
p rchybridiz ing so lutio n . T he m embrane was pro bed overnight at 65 °C and 
washed fo r 2 X I 0 min in 2 X SSC/ 0. ·1% sod ium dodecylsnl f.1te at 65°C, 
then for 4 X 20 min in 0. ·1 X SSC/ O.l'X, sodium dodecylsu!fi1tc at 65°C, and 
auton1diographcd. Autoradiograph s were scann ed and band in tensities 
determined as above. R elative band intensities were then standardi zed 
aga inst the density of the I 8S ribosomal R..NA bands. 
Statistical Analysis T he statistical signifi ca nce o f diffe rences between 
tnean vn lucs w as dc tc rn1ined using Stud en t 1 tests. 
RESULTS 
IGF-I and EGF Are Mitogenic in HaCaT Cells T h e mito -
gen.i c e fFects of t h e h ormon es o n 1-IaCaT cell s were examined b y 
m e asuring bo t h thymidine in corporatio n rates and cell-growth r ates 
in response to h ormone treatment. For th ymidine in corporatio n 
assays, 1-d post- conflu e nt mono layers of H aCaT cell s were incu-
bate d for 24 h in g rowth factor-fi-ee DMEM, h orm o n es were 
adde d , and thymidine incorpora tion rates were then m easure d after 
2 1 h as d escribe d in /llfnterinls n11d 1\/[et/wds. T h e ra te of th ymidine 
incorpo ration has bee n sh own to b e a va lid indicator of mitoge nic 
activity in keratinocytes [1 2] . Cell-growth rates were measured b y 
in c ubating HaCaT cells, initi a ll y a t 10% confluence. with each 
h o m10ne and dete rmining t h e r e lative number of ce ll s p e r well after 
4 d as d escribe d in 1\tfnterin/s n11d Meth(Jds. 
As sh o wn in Fig 1 (a-f) , IGF-1 and EGF inc re a sed thymidine 
incorporation rates by 8.5- and fiv e told a nd ce iJ number b y 1.35-
and 1. 7-fold , resp ective ly. bFGF (30 n g/ml) cau sed a n vofo ld 
inc rease in thymidin e incorpora tion rate without affecting cell-
g ro wth rate. The oth e r h o rmo n es, d exameth aso n e and retinoi c 
ac id , were not mitogenic b y e it h e r assay, retinoic acid actua ll y 
inhibi ting cell g rowth at 10 - r. M (Fig 1 a,d) . 
EGF Inhibits IGFBP-3 Production by HaCaT Cells Whereas 
IGF-1 Increases IGFBP-3 Levels T h e five h o rmo n es were 
tes te d for their abi li ty to regulate lG FBP-3 produc tion b y HaCaT 
cell s. After inc ubati o n of the ce ll s in g rowth f.,ctor-6:ee DMEM for 
24 h, hormones were a dded at the same con centratio n s u sed in th e 
mitogenic a ssays , a nd t h e cells were then g ro wn for 4 d w ith d a ily 
c h anges o f the h o rmones in fresh m e dium. T hi s re p eated treatm e nt 
was found to b e n ecessary to o b ser ve sig nifi can t ch an ges in 
IGF13P-3 levels in conditioned m e dia. Figure 2a sh o w s a n alys is b y 
W este rn Ligand blotting of the amount o fiG FBP-3 appearing in th e 
48-h p e riod following the fina! addition · of h ormones at m all.;mal 
concentratio n s . M ost obviou s is the marke d inhibitio n of IGFBP-3 
b y EGF. IG F-1 cause d an inc rease in l GFBP-3 band in tensity, 
w h e r eas the oth e r h o rmo nes h ad Littl e d e tecta ble efFect. B and 
d e n sit ies w e re quantifi e d by o ptica l scanning as d escribed in 
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Figure L IGF-1 and EGF arc mitogenic in HaCaT cells. Effect ofhonnone treatment o n thymidine incorporation rates (a- c) and cell growth rates (d- e). 
Afte r 24 h in g rowth factor-fi·ee medi um, post-confluent monolayers of HaCaT cell s were incubated with each hormone at the concen trations indicated . 
After 21 h, thymidine inco rporation rates were m easured as in Materials a111/ Methods (a- c). Fpr ce ll-growth assays , HaCaT cell s were plated at 10% confluence 
and incubated with each honnone for 4 d . T h en relative cell number was de termined as in Materials a11d Mctlwds (d- e). C.mlrol , untreated; /GP-1, 100 ng/ ml 
IGF-1; EGF, 30 ng/ ml EGF; bFGF, 30 ng/ml bFGF; Dex, 10- 7 M dexamethasone; R.A, 10- '' M re tinoi c acid. Data points represent m eans of triplica te 
(thymidine inco rpo ratio n) or quadruplicate (cell counting) well s ::': SD. *p < 0.01, **p < 0.001 versus contro l group. 
Materials a11d Methods. As shown in Fig 2b , JGF-1 ca used a variable 
(mean, twofold) increase in IGFBP-3 in the medium, whereas EGF 
caused a twentyfold reduction in IGFBP-3 levels. Retinoic acid and 
bFGF slightly reduced !GFBP-3 le vels, wh ereas dexamethasone 
had no significant effect. 
T he concen tration dependence of these effects is shown in Fig 
3a-e. Stimulation of I GF~P-3 levels in conditioned medium by 
lGF-1 was half-maximal at approJ!imately 10 ng/ml (Fig 3a) . The 
reduction in IGFBP-3 caused by EGF was highl y reproducible and 
ha)f maximal at 3 ng/ml (Fig 3b). T he slight reduction caused by 
bFGF was half maximal at 3 ng/ml (Fig 3c), whereas the effect of 
retinoic acid was half maximal at approximately 10 - H M (Fig 3d) . 
Dexamethasone from 10 - 11 to 10- 7 M caused changes ofless than 
1 ou;., in IGFBP-3 level (Fig 3e). 
EGF Reduces IGFBP-3 mRNA Levels in HaCaT Cells To 
in vestigate the mechanism behind the changes in IGFBP-3 levels in 
conditioned media ca used by !GF-l and EGF, we measured the 
levels ofTGFBP-3 mRNA in HaCaT cells after treatment with each 
hormone. HaCaT cells were incubated in growth factor-fi-ee 
DMEM for 24 h and then grown in the presence of each hormone 
for 2 d with daily changes of hormone in fresh medium. Total R . .NA 
was then prepared, and the relative levels of IGFBP-3 mil...NA were 
de tennined by Northern analysis as described in Materials and 
Methods . As shown in Fig 4a, IGF-I stimulation oflGFBP-3 was not 
accompanied by an increase in IGFBP-3 mR.NA. Densitometric 
sca1ming of triplicate lanes (gel not shown) revealed that IGF-1 in 
fact caused a slight (approximately 0.2-fold) reduction in IGFBP-3 
mRNA band intensity (Fig 4b). The red uction in IGFBP-3 levels 
after EGF treab11ent, however, was accompanied by a highly 
signifi cant fivefold reduction in IGFllP-3 mRNA compared to 
control untreated cells (Fig 4/t). 
DISCUSSION 
We have investigated the regulation of IGFBP-3 production in 
HaCaT cells, a keratinocyte cell line exhibiting purely basal 
characteristics . Several hormones known to be important in the 
regulation of skjn growth were tested, resulting in the following 
observations: i) IGF-1 and EGF are potent mitogens ofi-IaCaT cells, 
as they are of other keratinocyte cultures [2,12] ; ii) IGF-1 raises the 
level ofJGFBP-3 in cell-conditioned medium by a mechanism that 
is not dependent on increases in lGFBP-3 mRNA; iii) EGF is a 
potent inhibitor of IGFBP-3 synthesis, significantly reducing its 
protein and mRNA level; iv) bFGF and re tinoic acid inhibit 
IGFBP-3 production only slightly; and v) dexam ethasone has no 
significant effec ts on [GFBP-3 level. 
· The effect of JGF-T on IGFBP production has been studied in 
several ce ll types. Receptor-mediated IGF-1 stimulation of 
!GFBP-3 with concomitant increases in IGFBP-3 mR . .NA has been 
demonstrated in human bone cells and osteosarcon1as [27] and a 
bovine l<idney epithl:'lial cell line [28]. Receptor-independent IGF-l 
stimulation of IGFBP-3 has been demonstrated in a human breast 
cancer cel.l line [29], human dermal fibrobla sts [30,31], and a 
human squamous cell carcinoma line [31]. In dermal fibroblasts, the 
IGFBP-3 stimulation was shown to be independent of increased 
IGFBP-3 mRNA [32] and due to increased IG FBP-3 release 
[30,31]. From these studies and our findings presented here, it 
appears that both of the major cel.l types in skin, dermal fib roblasts 
and epidermal keratinocytes , share a similar mechanism ofiGFBP-..1 
regulation hy JGF- l. Whetl~er tlus involves IGF-1-mediated release 
of IGFBP-3 frOIJ1 keratinocytes remains to be investigated, but by 
analogy with the simil:1r IGF-l effect observed in the squamous cell 
carcinoma ~ne [31], the I.GF receptor is unlikely to be involved. 
Here we demofjStrf1ted that in HaCaT cells the effect is independent 
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Figure 2. H ormonal effects on IGFBP-3 product ion in HaCaT 
cells. Post-confluent monolaycrs of HaCaT cells were treated with fo ur 
daily additions of each ho rmone, then 2 d after the fina l addi tion lGFI3P-3 
in cell-conditioned media were analyzed by Western ligand blotting as in 
Materials mtd Methods. a, autoradiogram of Western ligand blot. C, control 
(untrea ted) ce ll s: I. 100 ng/ml lGF-1; E, 30 ng/ml EGF; F, 30 ng/ ml bFGF; 
D, 10- 7 M dexamethasone; R , 10- " M rctinoic acid. b, scanning densitom-
etry of Western ligand blot autoradiographs showing band intensities 
relative to control un treated ce ll s afte r horn1onc trcat•nen t at th e above 
concentrations. Bars represent the means of three sepa rate experiments ::t 
SD . *p < 0.001 ve rsus control group. 
of increases in IGFBP- 3 mR.N A and so pro bably does no t req ui re 
increased IGFBP-3 syn thes is. IGF-I-mediated protection o f re-
leased IGFBP-3 from proteolysis is a.lso no t likely to be in volved, 
because in a previous study we fo und no such pro teolytic activity in 
HaCaT - conditioned media [7). 
In contrast to IG F-1 , EGF appears to have o pposing effects on 
IGFBP-3 production in ke ratinocytes an d fibroblasts. In Swiss 3T3 
cells, EGF stimulated IG FBP-3 leve ls in condi tioned m edi a [21), 
whereas in ,HaCaT cells w e observed inhibition of IGFBP- 3 
syn thesis using the sam e treatment protocol. T here are o the r 
reports of IGFB P-3 produ ction being stimul ated by EGF, for 
example in porcine granulosa cell s [33) an d sheep thyro id ce lls [34), 
but th e o n.l y o ther published example ofEGF inhibi tion of!GFBP- 3 
productioD interestingly occurs in another epithe lial cell line, one 
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Figure 3. Concentration dependen ce of hormonal effects on 
IGFBP-3. Post-confluent monolayers of 1-JaCaT cells were treated with 
fo ur daily additions of each hormone at the concentra tions indicated. Two 
days after the fi nal addition, IGFB P-3 in the cell conditioned media was 
measured by scanning densitometry of Western ligand blots as in Mnterinls 
a11d i\tfetlwds. Bars represent the me~1n s of three separate cxperj rncn ts ± SO. 
*p < 0.001 versus control group . 
derived from murine m ammary gland [35). In HaCaT cells, the 
mechanism of inhibition of IGFBP-3 synthesis by EGF rem ains to 
be d etermined but appears to invo lve e ither inhibi tion of IGFBP-3 
gene transcrip tio n o r changes in IGFBP-3 mR.NA stabili ty, or bo th . 
T h e regul ation of IG FBP-3 in basa l ke ratin ocytes by IGF-1 and 
EGF is significan t fo r several reasons. Basal ke ratinocytes are the 
m ain epidermal targets for IGF-1 and EGF, because IGF [5] an d 
EGF [1 3, 14) receptors are concen trated in the basa l layer. IGFBP-3 
secre tion by basal keratinocytes does decrease th eir sensitiv ity to 
IGF-I [7), so, conversely, inhibi tion of IGFBP-3 syn thesis by EGF 
could significantly increase their sensitivi ty to IGF-1, resul ting in a 
syn ergisti c e ffect of EGF and IG F on basal keratinocyte growth . 
O ne preceden t fo r this type of g rowth-factor co-operation is the 
o bserva tion tha t tumor n ecrosis fac tor-a bo th inhibits IGFBP-3 
production and increases IGF-1 sensitivity in fib ro blasts, w hereas 
transform ing grow th f.,c to r- /31 has the opposite effects [36]. Syn-
ergism between IGF-1 m1d EGF ac tion has been demonstrated 
previously in keratinocytes, in w hi ch IGF-1 up-regulates expression 
of the EGF receptor [37], an d in fibro blasts, in w hich EGF 
stimulates IGF-I re lease in 3T3 cells in a possible au tocrine loop 
[38) . T h e inhibi tion ofi GFBP-3 synthes is thro ugh the EGF receptor 
on k eratin ocytes may be a further example of this syn erg ism and 
ma y be especially significan t in the hyperproli fe ration of basa l 
keratinocytes occurring in ps01·iasis. In p sori asis, bo th the EGF 
receptor and its epide rm all y de ri ved li g~nd , transforming growth 
factor-a, are overexprcsscd [39] . B ased on our findin gs, we suspect 
that the resul ting increase in stimulation of the EGF receptor is 
likely to result in suppression of IGFBP-3 in the basal epide rmis. 
T hu s, IGFBP-3 suppression , togethe r w ith the overexpression of 
606 WR.A IG J-IT AND WERTHER. 






u 80 ~ ~ 





r:n 20 LL 
£! 
0 
1.0 100 0.3 30 
control ng/ml ng/ml 
IGF-1 EGF 
Figure 4. EGF causes a reduction of IGFBP-3 mRNA level in 
HaCaT cells. Post-confl uent monolaycrs ofHaCaT ce ll s were treated with 
two daily add itions of !GF-1 or EGF at the concentrations indicated, and 20 
J.Lg total R.NA from the treated cells was analyzed on a Northern blot 
probed with a 32P-Iabelcd human IGFB P-3 eD NA as in Materials mul 
Met hods. a, autorad iograph of Northern blot showing the 2.6-kb IGFBP-3 
mRNA . C, control (un treated) cell s; I I.IJ• 1.0 ng/mll GF-1; I 100 , 100 ng/ml 
lGF-1; E0 .3 , 0.3 ng/ml EGF; E30 , 30 ng/ml EGF; 285, 185, positions of 285 
and '185 ribosomal I~ As as determined by ethidium bromide fluorescence 
of transferred RNA. l1, scanning densitometry of Northern au to radiograms, 
performed in tripli ca te . T he graph shows the optical densities of sc:mned 
triplicate IGF.BP-3 mRNA bands, following honnone treatment at the 
above concentrations, relative to contro l, untreated samples. R elative 
optica l densiti es were standardized against the o ptica l density of the 185 
ribosomal I~ A band in each lane. Bars represent means of tl;plica te lanes 
:±: SO. *p < 0.02 versus control group. 
IGF-1 receptors known to occur in psoriasis (5] , is likely to result in 
significant IGF-1-drive n keratinocyte pro life ration . It is also possi-
ble th at simila r syn ergisti c effects b etween mitogenic growth factors 
and JGFBP- 3 increase IG F- 1-driven hyp erproliferatio n of basal 
keratinocytes in other epiderm al di seases or during w o und h ealing. 
Because HaCaT cells are a spontan eously immorta lized kerati -
nocyte lin e, we cannot rule out the possibility th at changes may 
h ave occurred in their regu lation b y growth factors. However, we 
h ave shown that their g rowth response, to EGF and IGF-1 at least, 
is like that of normal cul tured keratinocytes. To the extent th at we 
can extrap o late o ur o bservations to keratinocytes i11 11i11o, we 
conclude th at EGF and IGF-1 could alter th e IGF-1 sen sitivity of the 
b asal e pidermis by regulating th e production o f th e major IGF 
binding protein of the basal keratinocyte, lG FBP-3. 
C] vfl is the recipient of a Royal C hildreu's Hospital Post-doctoral R csl'arclt 
Fellows flip. 
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